10 Year History
Bang & Olufsen Medicom has been active in the inhalation development range for the past 10 years. We have developed several pMDI devices that can be used for Asthma and Chronic Obstructive Pulmonary Disease (COPD).
The latest addition to the inhaler range, Insulair®, a disposable breath-actuated device, is designed for use with liquid drug formulations suitable for pMDIs and the inhaler offers improved pulmonary drug delivery for systemic treatment of diseases, including diabetes. We have also developped Asmair®, a pMDI for Asthma and COPD.
Inhalation Expertise
Bang & Olufsen Medicom offers a range of pMDI (pressurised metered dose inhalers) both breath-actuated as well as press and breath solutions. The products share a common dose counting platform and are all designed to be easy-to-use and discreet in their appearance.
In addition, to the pMDI solutions, Bang & Olufsen Medicom is also involved in dry powder inhalers. Information on Asmair® or information on Insulair®.